Convergent cross-species pro-cognitive effects of RGH-235, a new potent and selective histamine H3 receptor antagonist/inverse agonist.
Némethy Z, Kiss B, Lethbridge N, Chazot P, Hajnik T, Tóth A, Détári L, Schmidt É, Czurkó A, Kostyalik D, Oláh V, Hernádi I, Balázs O, Vizi ES, Ledneczki I, Mahó S, Román V, Lendvai B, Lévay G.
Némethy Z, et al. Among authors: roman v.
Eur J Pharmacol. 2022 Feb 5;916:174621. doi: 10.1016/j.ejphar.2021.174621. Epub 2021 Dec 26.
Eur J Pharmacol. 2022.
PMID: 34965389